Dr. M. M. Karindas is the President of the WAMS, the World Academy of Medical Sciences, where he has been serving as its leader for more than two decades now. Having extensive experience as a research scientist in Clinical and Molecular Oncology, he is the holder of landmark research studies including the "Multicellular Origin of Cancer" and "Oncogenetic Evolution" as well as the OCA/OTA/OCATA and ECE research studies. He is the creator and writer of the KGS, the “Karindas Grading System”, the all-encompassing universal paradigm of tumor grading and a new integral method of clinical management in oncology. He is also the writer and declarant of the phenomenal "International Declaration of Oncogenesis" whose Part V (OCA/OTA/OCATA in Oncogenesis) will be presented by him at our World Congress of "Cancer Science and Therapy”-2018 in Madrid. Having his main research interests in "Oncogenesis", "Cancer Metastasis", "Cancer Stem Cells", "Tumor Cell Biology", "Molecular Oncopathology", "Cell Signaling", "Signal Transduction", "Extracellular Matrix" and the "Origin and Evolution of Cancer ", he is currently busy working on the creation and establishment of a new medical algorithmic system which will universally be used in oncology as well as other fields of medicine.
Oncogenesis, Cancer Metastasis, Cancer Stem Cells, Tumor Cell Biology, Molecular Oncopathology, Cell Signaling, Signal Transduction, Extracellular Matrix and the Origin and Evolution of Cancer
Dr. Wassil Nowicky — Dipl. Ing., Dr. techn., DDDr. h. c., Director of “Nowicky Pharma” and President of the Ukrainian Anti-Cancer Institute (Vienna, Austria). Has finished his study at the Radiotechnical Faculty of the Technical University of Lviv (Ukraine) with the end of 1955 with graduation to “Diplomingeniueur” in 1960 which title was nostrificated in Austria in 1975. Dr. Wassil Nowicky became the very first scientist in the development of the anticancer protonic therapy and is the inventor of the preparation against cancer with a selective effect on basis of celandine alkaloids “NSC-631570”. He used the factor that cancer cells are more negative charged than normal cells and invented the Celandine alkaloid with a positive charge thanks to which it accumulates in cancer cells very fast. Thus, Dr. Nowicky is invited as an Honorable Speaker to take part in many scientific international congresses and conferences in USA, Australia, Japan, UAE, Europe. Author of over 300 scientific articles dedicated to cancer research. Dr. Wassil Nowicky is a real member of the New York Academy of Sciences, member of the European Union for applied immunology and of the American Association for scientific progress, honorary doctor of the Janka Kupala University in Hrodno, doctor “honoris causa” of the Open international university on complex medicine in Colombo, honorary member of the Austrian Society of a name od Albert Schweizer. He has received the award for merits of National guild of pharmasists of America. the award of Austrian Society of sanitary, hygiene and public health services and others.
Daniela Capdepon MD, graduate of the University F. Medical Barceló in 2001 with honors and highest academic average. Make residency in Internal Medicine at the Municipal hospital and COBA oriented Graduate Clinical Oncology from 2002 to 2004. Then I began to study the specialty of Clinical Oncology at the University of Salvador, trained in gastric tumors in Udaondo Hospital, Hospital Marie Curie Cancer Center and Henry Moore at where we learned to prepare and deliver chemotherapies and concurrences to form the pallium Center for palliative treatment of pain. Graduated in the specialty of clinical oncologist and palliative medicine subspecialty in Pain in 2006 of Salvador University, Buenos Aires. Oncologist at Work as outpatient and outpatient chemotherapy treatments made in Municipal Hospital and Italian Society of Zarate and Campana. Fellow in Fundaleu as subinvestigadora in Oncohematology and where do my training in liquid tumors, LLC, ALL MM, NHL LH. During 2006-2007. In 2008 I built my own Cancer Center, of which I am the owner and medical director, is Campana Cancer Center, where cancer care is done in outpatient chemotherapy treatments and pain and palliative treatments. Together with a specialized team that works with me. We also conduct Cancer Center, clinical research protocols in various tumors. Starting a new labor stage in the province of Entre Rios as oncologist responsible for the service in Peru Galarza General Hospital. And St. Joseph Medical.
Dr.Achour Radhouane is an associate professor at the faculty of medicine of Tunis-Tunisia; He has published many basic and clinical articles in relation to gynecology and obstetrics; His research interests include Rare Diseases in gynecology and prenatal diagnosis. He serves as associate professor, Emergency Department of Gynecology and Obstetrics in maternity and neonatology centre Tunis Tunisia. He also serves as the member of the editorial team for Asian Pacific Journal of Reproduction, the Global Journal of Rare Diseases, Journal of Neonatal Biology, Current pediatric research, Obstetrics and Gynecology: Open access, Pediatrics and Health Research and Member of the Science Advisory Board.
Dr. Yury Evgeny Razvodovsky is currently holding a position of Professor in International Academy of Sobriety. He has worked as associate professor in the Department of Psychiatry and a senior research scientist in the Scientific Laboratory (Alcohol and Drug-Related Problems Research Group) at the Grodno State Medical University (Belarus). He has published about 1000 papers in English and Russian language peer-reviewed journals and 30 monographs. He is a founding member of the International Society of Addiction Medicine (ISAM), presiding member of the International Academy of Sobriety (IAS), national representative for Belarus of World Suicidology Net and is an active member of National Association of Psychiatrists. His research interests include the epidemiology of suicides and different aspects of alcohol and drug-related problems.